Financhill
Sell
42

SRPT Quote, Financials, Valuation and Earnings

Last price:
$22.01
Seasonality move :
10.38%
Day range:
$21.10 - $22.52
52-week range:
$10.42 - $129.84
Dividend yield:
0%
P/E ratio:
20.50x
P/S ratio:
0.91x
P/B ratio:
1.69x
Volume:
2.3M
Avg. volume:
3.6M
1-year change:
-81.77%
Market cap:
$2.2B
Revenue:
$1.9B
EPS (TTM):
-$2.89

Earnings Data

Next earnings date for SRPT
Feb 25
2026
Most recent earnings per share
-$1.80
Missed by $1.42
(Nov 3/2025)
Consensus Estimate
-$0.37
(Nov 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SRPT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $379.5M -- -- -$0.73 --
11/03/2025 Q3 $337M $399.4M -$1.80 -$0.37 -$1.42
08/06/2025 Q2 $531M $611.1M $1.89 $1.16 $0.73
05/06/2025 Q1 $684.1M $744.9M -$4.60 -$0.65 -$3.95
02/26/2025 Q4 $631M $658.4M $1.61 $2.06 -$0.45
11/06/2024 Q3 $405.1M $467.2M $0.34 $0.37 -$0.03
08/07/2024 Q2 $387.3M $362.9M $0.07 $0.47 -$0.40
05/01/2024 Q1 $375.4M $413.5M $0.36 $0.41 -$0.05
02/28/2024 Q4 $386.2M $396.8M $0.43 $0.37 $0.06
11/01/2023 Q3 -- $331.8M -$0.46 -- --
08/02/2023 Q2 -- $261.2M -$0.27 -- --
05/02/2023 Q1 -- $253.5M -$5.86 -- --
02/28/2023 Q4 -- $258.4M -$1.24 -- --
11/02/2022 Q3 -- $230.3M -$2.94 -- --
08/02/2022 Q2 -- $233.5M -$2.65 -- --
05/04/2022 Q1 -- $210.8M -$1.20 -- --
03/01/2022 Q4 -- $201.5M -$1.42 -- --
11/03/2021 Q3 -- $189.4M -$0.60 -- --
08/04/2021 Q2 -- $164.1M -$1.02 -- --
05/05/2021 Q1 -- $146.9M -$2.11 -- --
03/01/2021 Q4 -- $145.1M -$2.40 -- --
11/05/2020 Q3 -- $143.9M -$2.50 -- --
08/05/2020 Q2 -- $137.4M -$1.93 -- --
05/06/2020 Q1 -- $113.7M -$0.23 -- --
02/26/2020 Q4 -- $100.1M -$3.16 -- --
11/07/2019 Q3 -- $99M -$1.70 -- --
08/07/2019 Q2 -- $94.7M -$3.74 -- --
05/08/2019 Q1 -- $87M -$1.07 -- --
02/27/2019 Q4 -- $84.4M -$2.05 -- --
10/24/2018 Q3 -- $78.5M -$1.15 -- --
08/08/2018 Q2 -- $73.5M -$1.67 -- --
05/03/2018 Q1 -- $64.6M -$0.55 -- --
03/01/2018 Q4 -- $57.3M -$0.37 -- --
10/25/2017 Q3 -- $46M -$0.78 -- --
07/19/2017 Q2 -- $35M -$1.15 -- --
04/27/2017 Q1 -- $16.3M $1.50 -- --
02/28/2017 Q4 -- $5.4M -$1.62 -- --
10/27/2016 Q3 -- -- -$1.18 -- --
07/19/2016 Q2 -- -- -$1.35 -- --
05/05/2016 Q1 -- -- -$1.31 -- --
02/25/2016 Q4 -- $1.3M -$1.44 -- --

Sarepta Therapeutics, Inc. Earnings Questions

  • How Much did Sarepta Therapeutics, Inc. Generate in Revenue Last Quarter?

    Sarepta Therapeutics, Inc. reported $399.4M worth of top line sales in its most recent quarter.

  • Did Sarepta Therapeutics, Inc. Beat Earnings Last Quarter?

    Sarepta Therapeutics, Inc. announced earnings per share of -$1.80 which represents a miss of analyst forecast a -$0.37 per share.

  • Is Sarepta Therapeutics, Inc. Profitable?

    Sarepta Therapeutics, Inc. reported $230.1M that represents $2.30 per share over the last quarter.

  • What is the Analyst Consensus for Sarepta Therapeutics, Inc. EPS Next Year?

    Sarepta Therapeutics, Inc.'s earnings are forecast to decrease from $2.34 per share to $4.02 per share next year representing a decrease of -95.56%.

  • When is Sarepta Therapeutics, Inc.'s Earnings Date?

    Sarepta Therapeutics, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.

Buy
54
UNF alert for Dec 23

UniFirst Corp. [UNF] is up 0.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock